• LinkedIn
SFL Regulatory Affairs & Scientific Communication Ltd.
  • About SFL
    • Why SFL
    • Team
    • Associations
    • History
    • Awards
    • Ethics
  • Services
    • Regulatory Affairs
    • Quality Assurance & GxP Compliance
    • Medical Affairs & Communication
    • Market Access & Reimbursement
    • Public Affairs & Regulatory Intelligence
    • Medical Devices, Combination Products and IVDs
    • Pharmacovigilance & Clinical Safety
    • Supply Chains of Medicines and Devices
    • Legal & Healthcare Compliance
    • Swiss Support
    • UK Support
    • Clinical Trials support
  • Clients
    • Testimonials
    • Cases
  • Trainings
    • Customized training
    • Webinars
  • News
    • News
    • Newsletter
  • Careers
  • Contact
  • Search
  • Menu Menu

SFL organizes the MPP conference on combined products

The 9th edition of the Medtech & Pharma Platform (MPP) Annual Conference, organized by SFL will take place on 8 September 2022 in Basel, Switzerland.

Dedicated to ‘How combined products address health challenges’, the conference focuses on products and solutions combining medicinal product, medical device and digital health components (combined products). The event gathers stakeholders from industry, patient organizations, academia, notified bodies and public health authorities to exchange knowledge, collaborate in technology and regulatory areas, as well as to promote product development and innovation.

Shayesteh Fürst-Ladani, the Head of SFL Group, will open the conference and moderate a discussion on the regulation of combined products with high caliber speakers from the FDA, Swissmedic, Team-NB and Novartis.

Several SFL team members – including Anja Bührer, Deputy Head of SFL Group and Head of Regulatory Affairs, and Delphine Guérin, Director Business Development – will be in attendance at the SFL booth and happy to answer questions and provide information to the conference participants. SFL services include strategic and operational regulatory affairs and quality assurance support from early development to launch and maintenance on the market, as well as medical affairs, market access, pharmacovigilance, healthcare compliance and public affairs support.

Switzerland – Main Office

SFL Regulatory Affairs & Scientific Communication GmbH
Aeschenvorstadt 52 | CH-4051 Basel
Email: office@sfl-services.com
Phone: +41 61 361 9443

© Copyright 2023 - SFL Regulatory Affairs & Scientific Communication GmbH | Terms and Conditions | Privacy Statement | Cookies Policy
Scroll to top